Company Name: PNE AG ISIN: DE000A0JBPG2   Reason for the research: Update Recommendation: Buy from: 13.05.2025 Target price: 19,00 Euro Target price on sight of: 12 Monate Last rating change: 02.02.2023: Hochstufung von Hinzufügen auf Kaufen Analyst: Dr. Karsten von Blumenthal First Berlin Equity Research hat ein Research U [ … ]

Singulus delivered a disappointing Q1 marked by sharply lower order intake and revenue, largely due to delayed investment decisions. However, the margin profile improved significantly thanks to an improved product mix supported by the semiconductor segment. Management reaffirmed its full-year guidance, citing a solid backlog and recent new orders in semiconductors and solid-state batteries with additional solar orders expected in the near term. That said, mwb research’s analysts continue to view the lower end of the sale guidance range as achievable, albeit order intake will need to accelerate going forward. Strategically, the company is progressing with its transformation toward a more balanced and higher-value segment mix. Leveraging its unique integration of vacuum deposition and wet-chemical technologies, Singulus is positioning itself to address niche, high-growth markets such as MRAM, micro-LEDs, medical coatings, and next-generation energy storage. This shift supports a more resilient, less cyclical business model with structurally improved profitability. mwb research’s analysts maintain their Speculative BUY rating and price target of EUR 4.00. The full update can be found under https://research-hub.de/companies/singulus-technologies-ag

Verbio’s Q3 25 results showed a 3.5% yoy decline in revenues to EUR 394.9m but exceeded consensus expectations by 5.6%. EBITDA came in at EUR 8.2m, below the EUR 15m forecast, but a 12.7% improvement vs. Q3 24. In the Biodiesel segment, revenue dropped 3.4% yoy, but EBITDA rose 47.4%, driven by better cost management despite lower volumes. In the Bioethanol/Biomethane segment, revenue fell 3.5% yoy, with EBITDA declining by EUR 8.8m yoy due to ramp-up costs in Nevada, US. Verbio expects FY 25 EBITDA to be at the lower end of its guidance, with net debt to stay below EUR 190m by year-end. Focus remains on Nevada’s ramp-up and operational efficiency. After adjusting their model and slightly lowering estimates due to prolonged pressure, mwb research’s analysts maintain their BUY rating with an unchanged PT of EUR 15.00. The current share price, despite a c. 47% increase from last month's low, remains an attractive entry point with 42.9% upside potential. Register here to join the Earnings Call today at 2pm (CEST): https://research-hub.de/events/registration/2025-05-13-14-00/VBK-GR. The full update can be downloaded under https://www.research-hub.de/companies/Verbio%20SE

United Internet (UI) reported stronger-than-expected Q1 25 results. Revenue rose 4% yoy to EUR 1.6bn (+2% vs consensus), while adj. EBITDA was flat yoy at EUR 343m but beat expectations by 7%, helped by lower 1&1 network build costs (EUR 67m). The Business Applications segment outperformed, driven by strong aftermarket demand. EBIT fell 13% yoy to EUR 163m due to roll-out costs and higher depreciation. UI added 150,000 customers in Q1, reflecting solid demand. For FY25, UI raised revenue guidance to ~EUR 6.45bn (+2.3% yoy) and maintained adj. EBITDA at ~EUR 1.35bn (+4% yoy). Shares are up ~25% over the past month, supported by optimism around cloud services and expected benefits from Germany’s EUR 500bn infrastructure fund. mwb research’s analysts reiterate to BUY with new PT of EUR 25.00 (prev. EUR 23.00).The full update can be downloaded https://www.research-hub.de/companies/United%20Internet%20AG

Deutsche Rohstoff reported a solid Q1 2025, with revenues up 6% yoy to EUR 59.1m, driven by higher oil volumes and a favorable production mix, despite lower oil prices. Oil production rose 9%, reflecting strong well performance from late 2024. The EBITDA margin remained stable at 73.2%, with higher personnel costs offsetting efficiency gains. Free cash flow was strong at EUR 22.1m, enabling further deleveraging as net debt fell 14% to EUR 134.3m. The company’s 2025 drilling program is underway with 4 wells drilled and 10 planned, down from initially 12 due to oil price volatility), while maintaining flexibility for further adjustments. Guidance was confirmed at EUR 170– 190m in revenue and EUR 115–135m in EBITDA (based on WTI USD 60), supported by a robust hedge book and strong liquidity. With a >50% EV/EBITDA discount to US peers and a shareholder yield over 6%, mwb research’s analysts reiterate their BUY rating and PT of EUR 47.00. The full update can be downloaded under https://www.research-hub.de/companies/Deutsche%20Rohstoff%20AG

Company Name: q.beyond AG ISIN: DE0005137004   Reason for the research: Update Recommendation: BUY from: 13.05.2025 Target price: EUR 1.30 Target price on sight of: 12 months Last rating change: Analyst: Philipp Sennewald Q1 in line as profitability improves further Yesterday, QBY released a solid set of Q1 results, showing stea [ … ]

Fraport's Q1 2025 results were mixed, with revenues of EUR 869m up 6% yoy and broadly in line with expectations, but EBITDA of EUR 177.5m missed by 7.5% due to the absence of prior-year one-offs and rising personnel costs. Strong performances in International Activities & Services and Ground Handling helped offset weaker-than expected Aviation revenues and continued cost pressures. Cash flow was weak, with free cash flow at EUR -353m due to higher concession fees and ongoing capex. The FY25 outlook was confirmed, including up to 64m passengers at Frankfurt, modest EBITDA growth, and no dividend. Given the EBITDA miss, soft traffic at Frankfurt, and rising costs, estimates are slightly lowered. mwb research’s analysts reduce their price target to EUR 62.00 (from EUR 65.00) and downgrade to HOLD (from BUY). The full update can be downloaded under https://www.research-hub.de/companies/Fraport%20AG

Company Name: Schaeffler AG ISIN: DE000SHA0019   Reason for the research: Update Recommendation: Buy from: 12.05.2025 Target price: 7.50 Last rating change: Analyst: Daniel Kukalj, CIIA, CEFA Attractive level to build up positions After a solid start (Q1 2025: Sales flat qoq, but slightly lower yoy; adj. EBIT margin at upper end  [ … ]

Company Name: Schloss Wachenheim AG ISIN: DE0007229007   Reason for the research: Q3 2024/25 results Recommendation: Buy from: 12.05.2025 Target price: €21 Target price on sight of: 12 months Last rating change: - Analyst: Simon Scholes First Berlin Equity Research has published a research update on Schloss Wachenheim AG (I [ … ]

Formycon’s Q1 2025 results showed a significant decline in revenue to EUR 5.3m, mainly due to the absence of prior-year milestone payments and weaker performance from FYB201. Adjusted EBITDA was negative, reflecting lower at-equity income and higher R&D spend. Nonetheless, full-year guidance was maintained. Operationally, the launch of FYB202 in the U.S. and Europe contributed EUR 0.74m in initial revenue, while FYB201 commercialization in the U.S. was paused by commercial partner Sandoz due to pricing pressure. Looking ahead, a proposed U.S. executive order may pressure biosimilar pricing but could also support adoption. mwb research’s analysts reiterate their BUY rating and EUR 50.00 price target, though acknowledge increasing regulatory risks in the U.S. market. The full update can be downloaded under https://www.research-hub.de/companies/Formycon%20AG